POINT BIOPHARMA GLOBAL INC (PNT)

US7305411099 - Common Stock

12.5  +0.02 (+0.16%)

After market: 12.51 +0.01 (+0.08%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
243.80M226.60M0.000.000.00
Operating Expenses
135.90M101.10M45.50M13.10M0.00
Research and Development
113.00M82.10M33.50M9.10M0.00
Selling, General, and Administrative Expenses
22.90M19.00M12.00M4.00M0.00
Operating Income
107.80M125.50M-45.50M-13.10M0.00
Interest Income/Expense
19.30M4.10M-100.00K-200.00K0.00
Income Before Taxes
127.10M129.60M-45.60M-13.30M0.00
Income Tax
30.60M31.30M300.00K100.00K0.00
Net Income
96.60M98.30M-45.90M-13.40M0.00
EBITDA
110.40M126.90MN/AN/AN/A
 
Per Share Data
EPS Diluted Total Ops
0.831.02-0.62-0.150.00
 
Statistics
Profit Margin
39.62%43.38%N/AN/AN/A
Operating Profit Margin
44.22%55.38%N/AN/AN/A

All data in USD

Charts